Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_assertion type Assertion NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_head.
- NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_assertion wasGeneratedBy ECO_0000203 NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_provenance.
- NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_assertion wasDerivedFrom befree-20140225 NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_provenance.
- NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_assertion SIO_000772 17934217 NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_provenance.
- NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_assertion evidence source_evidence_literature NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_provenance.
- NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_assertion description "[Furthermore, elevated mortalin level was also detected in the ER subgroup of HCC versus the recurrence-free state (where no cancer recurs for >1 year) (AUC = 0.833, sensitivity = 90.9%, specificity = 71.4%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP462761.RAH4St42L3t2RjGLstBLAniMCVd3epGj3ooCm-mKJ1-s4130_provenance.